AbbVie Market Capitalization from 2010 to 2024

ABBV Stock  USD 194.29  1.16  0.59%   
AbbVie Market Cap yearly trend continues to be fairly stable with very little volatility. Market Cap will likely drop to about 74 B in 2024.
Check AbbVie financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie's main balance sheet or income statement drivers, such as Depreciation And Amortization of 9.1 B, Interest Expense of 1.1 B or Selling General Administrative of 7.8 B, as well as many indicators such as Price To Sales Ratio of 3.39, Dividend Yield of 0.0289 or PTB Ratio of 17.19. AbbVie financial statements analysis is a perfect complement when working with AbbVie Valuation or Volatility modules.
  
Check out the analysis of AbbVie Correlation against competitors.

Latest AbbVie's Market Capitalization Growth Pattern

Below is the plot of the Market Cap of AbbVie Inc over the last few years. It is AbbVie's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in AbbVie's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 345.23 B10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

AbbVie Market Capitalization Regression Statistics

Arithmetic Mean110,993,503,333
Geometric Mean104,908,476,117
Coefficient Of Variation29.75
Mean Deviation27,781,843,911
Median131,127,740,000
Standard Deviation33,016,150,512
Sample Variance1090066194.7T
Range77.3B
R-Value0.44
Mean Square Error945387625.6T
R-Squared0.19
Significance0.1
Slope3,257,347,514
Total Sum of Squares15260926725.3T

AbbVie Market Capitalization History

202474 B
2023118 B
2013131.1 B

About AbbVie Financial Statements

AbbVie investors use historical fundamental indicators, such as AbbVie's Market Capitalization, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in AbbVie. Please read more on our technical analysis and fundamental analysis pages.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 50000 people.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for AbbVie Stock Analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.